What We're Reading: Page 361
Industry reads hand-picked by our editors
May 15, 2015
-
FierceBiotech
FierceBiotech's 25 most influential people in biopharma in 2015
-
Reuters
CA Senate votes to end beliefs waivers for school vaccinations
-
Wall Street Journal
UK gov't review calls for multibillion-dollar investments to combat superbugs
-
Reuters
UK's Circassia buys 2 asthma-focused firms for up to $377M
May 14, 2015
May 13, 2015
-
Contract Pharma
Lighthouse, Bosch form strategic partnership
-
FierceBiotech
More bad news for Takeda as cancer hopeful flops phase III
-
Reuters
Dengue outbreak presents big healthcare challenge to Brazilian president
-
Modern Healthcare
21st Century Cures legislative markup scheduled for Thursday
May 12, 2015
-
FierceBiotech
Caforio takes over as Bristol-Myers CEO
-
Associated Press
New blood tests, liquid biopsies, may transform cancer care
-
Fierce Biopharma
China gears up to change the rules of the game on drug sales
-
BPR
NJ Assembly committee approves biosimilar substitution bill
-
Reuters
Mylan chairman thinks Teva a bad cultural fit, would consider buying it anyway
May 11, 2015
May 08, 2015
-
Bloomberg
Liberia to be declared Ebola-free
-
Reuters
Novartis lung cancer drug wins European approval
-
Reuters
WHO adds hep C drugs to essential medicines list
-
In-Pharmatechnologist
Hospira to layoff 100 workers
Previous
